2012
Feasibility of Electronic Directly Observed Therapy for Pediatric Leukemia Patients
Cohen A, Krishnamurti L, Creary S. Feasibility of Electronic Directly Observed Therapy for Pediatric Leukemia Patients. Blood 2012, 120: 3538. DOI: 10.1182/blood.v120.21.3538.3538.Peer-Reviewed Original ResearchAcute lymphoblastic leukemiaMedication adherenceMaintenance therapyAdherence surveyAdherence ratesHealthcare workersPediatric sickle cell populationMaintenance therapy phaseMedication adherence surveyWeekly oral methotrexateDisease-free survivalAnti-retroviral therapyPediatric leukemia patientsHigher adherence ratesNon-adherence ratesRisk of relapseSelf-reported adherenceCommon pediatric cancerSickle cell populationEnd of studyGood overall adherenceYears of ageIntravenous vincristineMMAS-4Month regimen
2006
Acute renal failure from xanthine nephropathy during management of acute leukemia
LaRosa C, McMullen L, Bakdash S, Ellis D, Krishnamurti L, Wu H, Moritz M. Acute renal failure from xanthine nephropathy during management of acute leukemia. Pediatric Nephrology 2006, 22: 132-135. PMID: 17039332, DOI: 10.1007/s00467-006-0287-z.Peer-Reviewed Original ResearchConceptsTumor lysis syndromeAcute renal failureLysis syndromeXanthine nephropathyRenal failureTumor lysis syndrome prophylaxisOliguric acute renal failureT-cell acute lymphoblastic leukemiaLife-threatening complicationsAcute lymphoblastic leukemiaDiagnosis of patientsAggressive chemotherapyInduction chemotherapyUrinary xanthineUrine alkalinizationSerious complicationsLymphoproliferative malignanciesLymphoblastic leukemiaAcute leukemiaUrine measurementsPreemptive useNephropathyUric acid synthesisSyndromeHypoxanthine levels